The "U.S. Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type (Preclinical, Clinical, Commercial), Customer Type, Therapeutic Area, Region, and Segment ...

DUBLIN--(BUSINESS WIRE)--The "Small Molecule API Contract Manufacturer Quality Benchmarking (2nd edition)" report has been added to Research and Markets' offering. As pharmaceutical and ...

Dublin, Feb. 27, 2020 (GLOBE NEWSWIRE) -- The "Small Molecule API Contract Manufacturer Quality Benchmarking (5th Edition)" report has been added to ResearchAndMarkets.com's offering. Small Molecule ...

Wilmington PharmaTech ("WPT"), a U.S.-based specialty contract research, development and manufacturing organization (CRDMO) focused on complex custom small molecule API, today announced that it has ...

Small molecule API are highly beneficial in the diagnosis, treatment and prevention of a vast range of disorders and is useful as research tool to study biological function and develop new therapeutic ...

TEL AVIV, Israel--(BUSINESS WIRE)--Teva announced today its intention to divest its active-pharmaceutical ingredient (API) business, or "TAPI". TAPI is a global leader in the small-molecule API ...

Teva (NYSE:TEVA) plans to divest its active-pharmaceutical ingredient (API) business as part of its Pivot to Growth strategy to focus on its core business strengths. "The intent to divest TAPI will ...

Wilmington PharmaTech (“WPT”), a U.S.-based specialty contract research, development, and manufacturing organization (CRDMO) focused on custom small molecule API development and manufacturing, today ...

This month, the Joe Biden administration awarded $14 million to the API Innovation Center, a Saint Louis–based nonprofit that aims to remedy supply chain problems for active pharmaceutical ingredients ...

(MENAFN- EIN Presswire) EINPresswire/ -- The small molecule CMO/CDMO sector is experiencing robust growth fueled by evolving pharmaceutical industry needs and strategic outsourcing trends. As drug ...